Who founded Sus Clinicals?

Sus Clinicals was founded by Lawrence Schook in 2020.

How much funding has Sus Clinicals raised?

Sus Clinicals has disclosed $3.5M raised across 1 round.

Where is Sus Clinicals headquartered?

Sus Clinicals is headquartered in Cincinnati, US.

Sus Clinicals

Cincinnati, US · Founded 2020 · Delaware corporation

Find your way into Sus Clinicals

31 people in our graph share verified history with the Sus Clinicals team — schools, employers, funds. One of them is your warm intro.

Christopher Valeraunlockedknows Lawrence Schook · together at University of Illinois (overlapped)

×11knows the team · via University of Illinois

Sus Clinicals provides preclinical testing services using its Oncopig cancer model, a large-animal platform that induces tumors and other diseases on demand to generate predictive data for medical devices, drugs, and diagnostics. It serves healthcare and therapeutics developers seeking to accelerate drug and device development toward clinical trials.

Biotech Deep Tech Healthtech

Founders & leadership

Sus Clinicals was founded in 2020 by Lawrence Schook.

Lawrence Schook Founder · Chief Scientific OfficerLawrence Schook is Co-Founder and Chief Scientific Officer of Sus Clinicals, a preclinical testing company using large-animal disease models for drug and device development. He previously served as Vice President for Research at the University of Illinois and holds faculty positions in animal sciences and radiology.

Dr. Jessicca M. RegeChief Executive Officer

Stephen J BaggottNamed on SEC filing

Geoffrey T MarshallNamed on SEC filing

Jeffrey D WeedmanExecutive Chair & Co-Founder

Reported raises · per SEC filings

Form D private placements

$3.5M disclosed across 1 round · 2023

▶$3.5MraisedJan 2024 · 30 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Stephen J BaggottExecutive Officer, Director
Geoffrey T MarshallExecutive Officer, Director
Jeffrey D WeedmanExecutive Officer, Director

Offering amount: $5M
Amount sold: $3.5M
Minimum investment: $10K
First sale: Aug 2023
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

AngioDynamics19 shared keywordsAngioDynamics develops and manufactures medical devices aimed at treating serious diseases and improving patient outcomes. Founded in 1988, the company serves healthcare professionals and operates globally across North America, Europe, the Middle East, and South America.

Companies competing with Sus Clinicals for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Institutes of Health (NIH)National Institutes of Health	Phase II	2023	$964.3K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Ex-Cintrifuse CEO Jeff Weedman raises $4M for cancer research startup in Cincinnati - Cincinnati Business Courierbizjournals.com · Apr 2024

Frequently asked questions

What does Sus Clinicals do?: Sus Clinicals provides preclinical testing services using its Oncopig cancer model, a large-animal platform that induces tumors and other diseases on demand to generate predictive data for medical devices, drugs, and diagnostics. It serves healthcare and therapeutics developers seeking to accelerate drug and device development toward clinical trials.
Who founded Sus Clinicals?: Sus Clinicals was founded by Lawrence Schook in 2020.
How much funding has Sus Clinicals raised?: Sus Clinicals has disclosed $3.5M raised across 1 round.
Where is Sus Clinicals headquartered?: Sus Clinicals is headquartered in Cincinnati, US.